Hereditary Transthyretin Amyloidosis Polyneuropathy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Hereditary Transthyretin Amyloidosis Polyneuropathy Medications, Costs & Savings
Pharmacist insight
Anti-seizure medications require careful monitoring of blood levels to ensure therapeutic effectiveness. I advise patients never to switch between brand and generic without consulting their pharmacist, as even small differences in absorption can affect seizure control. Medication adherence is the single most important factor.
Angela C. Beverly, PharmD
About Hereditary Transthyretin Amyloidosis Polyneuropathy
Hereditary transthyretin amyloidosis polyneuropathy (hATTR-PN) is a rare, progressive genetic disorder that can significantly impact quality of life. The medications used to manage this condition are often very expensive, creating a substantial financial burden. TheDrugClub helps members access these vital prescriptions at discounted rates, making life-changing treatments more affordable.
Hereditary transthyretin amyloidosis polyneuropathy, or hATTR-PN, is a serious and often debilitating genetic condition. It's caused by a mutation in the transthyretin (TTR) gene, which leads to the production of abnormal TTR proteins. These misfolded proteins accumulate as amyloid fibrils in various tissues and organs throughout the body, particularly affecting the peripheral and autonomic nervous systems.
Over time, this amyloid buildup can damage nerves, leading to a range of symptoms. Patients may experience numbness, tingling, and weakness
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.